¼¼°èÀÇ ½ÉÆó ¹ÙÀÌÆÐ½º Àåºñ ½ÃÀå
Cardiopulmonary Bypass Equipment
»óǰÄÚµå : 1757658
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 06¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 270 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,053,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,161,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ½ÉÆó ¹ÙÀÌÆÐ½º Àåºñ ½ÃÀåÀº 2030³â±îÁö 2¾ï 2,090¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 1¾ï 9,900¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ ½ÉÆó ¹ÙÀÌÆÐ½º Àåºñ ½ÃÀåÀº ºÐ¼® ±â°£ÀÎ 2024-2030³â¿¡ CAGR 1.8%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 2¾ï 2,090¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ ½Ì±Û ·Ñ·¯ ÆßÇÁ´Â CAGR 1.4%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 1¾ï 4,720¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ´õºí ·Ñ·¯ ÆßÇÁ ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£¿¡ CAGR 2.6%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 5,420¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 3.3%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ½ÉÆó ¹ÙÀÌÆÐ½º Àåºñ ½ÃÀåÀº 2024³â¿¡´Â 5,420¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº ºÐ¼® ±â°£ÀÎ 2024-2030³âÀÇ CAGRÀ» 3.3%·Î 2030³â±îÁö ¿¹Ãø ½ÃÀå ±Ô¸ð 4,050¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 0.7%¿Í 1.5%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 1.0%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ½ÉÆó ¹ÙÀÌÆÐ½º Àåºñ ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

½ÉÆó ¹ÙÀÌÆÐ½º Àåºñ°¡ ½ÉÀå ¼ö¼ú, ÁßȯÀÚ Ä¡·á, ü¿Ü »ý¸í À¯Áö ºÐ¾ß¿¡¼­ Àü·«Àû Á߿伺ÀÌ ³ô¾ÆÁö´Â ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

½ÉÆó¿ìȸ¼ú(CPB)Àº ½ÉÀå ¼ö¼úÀÇ ÇÙ½ÉÀ¸·Î, ½ÉÀå°ú Æó¸¦ ¾ÈÀüÇÏ°Ô ¿ìÈ¸ÇØ¾ß ÇÏ´Â ¼ö¼ú Áß ÀϽÃÀûÀÎ ¼øÈ¯ ¹× È£Èí Áö¿øÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. °ü»óµ¿¸Æ¿ìȸ¼ú(CABG), ÆÇ¸· ġȯ¼ú, ¼±Ãµ¼º °á¼Õ ¼ö¼ú, º¹ÀâÇÑ ´ëµ¿¸Æ ¼ö¼ú µî¿¡ ³Î¸® »ç¿ëµÇ´Â ÀÌ Àåºñ´Â ¿Ü°ú Àǻ簡 Àü½Å °ü·ù¿Í »ê¼Ò °ø±ÞÀ» º¸ÀåÇϸ鼭 ¿òÁ÷ÀÓÀÌ ¾ø´Â ¹«Ç÷ »óÅ¿¡¼­ ¼ö¼úÀ» ÇÒ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù. Àü ¼¼°è¿¡¼­ ½ÉÇ÷°ü°è ÁúȯÀÇ ¹ßº´·üÀÌ Áõ°¡ÇÏ°í ¼±Áø±¹°ú ½ÅÈï ±¹°¡¿¡¼­ ¼ö¼ú °Ç¼ö°¡ Áõ°¡ÇÔ¿¡ µû¶ó CPB Àåºñ´Â »ý¸í À¯Áö¸¦ À§ÇÑ ÁßÀ縦 Áö¿øÇÏ´Â µ¥ ÀÖÀ¸¸ç, Àü·«Àû Á߿伺À» ´Ù½Ã ÇÑ ¹ø °­Á¶Çϰí ÀÖ½À´Ï´Ù.

ÀüÅëÀûÀÎ °³½É¼ú»Ó¸¸ ¾Æ´Ï¶ó ½ÉÀμº ¼îÅ©, ±Þ¼º È£Èí°ï¶õ ÁõÈıº(ARDS) ¶Ç´Â °³½É¼ú ÈÄ ÇÕº´ÁõÀÌ ÀÖ´Â ÁßÁõ ȯÀÚ¸¦ À§ÇÑ Ã¼¿Ü»ý¸íÀ¯Áö(ECLS) ¹× ü¿Ü¸·»ê¼ÒÈ­(ECMO) ÇÁ·ÎÅäÄÝ¿¡ ½ÉÆó¿ìȸ½Ã½ºÅÛÀÇ ÅëÇÕÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿ëµµÀÇ È®´ë·Î CPBÀÇ ¿ªÇÒÀº ¼ö¼ú Åø·Î¼­»Ó¸¸ ¾Æ´Ï¶ó ÁßȯÀÚ½Ç ¹× ÀÀ±Þ½Ç ȯ°æ¿¡¼­ »ý¸íÀ» ±¸ÇÏ´Â Áß¿äÇÑ ¿ä¼Ò·Î¼­µµ °­È­µÇ°í ÀÖ½À´Ï´Ù.

½Ã½ºÅÛ ¼ÒÇüÈ­, »ýüÀûÇÕ¼º ¼ÒÀç, ÀÚµ¿È­°¡ CPB ÀåºñÀÇ ¼º´ÉÀ» ¾î¶»°Ô Çâ»ó½Ã۰í Àִ°¡?

±â¼úÀÇ ¹ßÀüÀº º¸´Ù ÄÄÆÑÆ®Çϰí, È¿À²ÀûÀ̸ç, ȯÀÚ Áß½ÉÀÇ Â÷¼¼´ë CPB ½Ã½ºÅÛÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. °ü·ù ȸ·ÎÀÇ ¼ÒÇüÈ­, »ê¼Ò °ø±Þ±âÀÇ ³»ÀåÈ­, ÇÁ¶óÀÌ¹Ö ¾çÀÇ °¨¼Ò·Î Ç÷¾× Èñ¼®, ¿°Áõ ¹ÝÀÀ ¹× ½Ã¼úÀÇ º¹À⼺ÀÌ °¨¼ÒÇϰí ÀÖ½À´Ï´Ù. ¿ø½É ÆßÇÁ´Â Ç÷¾× ó¸® °³¼±°ú Àü´Ü ÀÀ·Â °¨¼Ò·Î ÀÎÇØ ¸¹Àº ȯ°æ¿¡¼­ ·Ñ·¯ ÆßÇÁ¸¦ ´ëüÇϰí ÀÖÀ¸¸ç, Æó¼â ·çÇÁ ȸ·Î¿Í »ýü ÀûÇÕ¼º ÄÚÆÃ(¿¹: ÇìÆÄ¸° °áÇÕ Ç¥¸é)Àº ¾ÈÀü¼ºÀ» ³ôÀ̰í Ç÷Àü »öÀüÁõ ¹× Àü½Å ¿°Áõ ¹ÝÀÀ ÁõÈıº(SIRS)ÀÇ À§ÇèÀ» °¨¼Ò½Ã۰í ÀÖ½À´Ï´Ù.

ÀÌ Ã·´Ü ½Ã½ºÅÛÀº ÅÍÄ¡½ºÅ©¸° ÀÎÅÍÆäÀ̽º, ½Ç½Ã°£ ¸Å°³º¯¼ö ¸ð´ÏÅ͸µ, ¿Âµµ, À¯·®, °¡½º ±³È¯ÀÇ ÀÚµ¿ Á¦¾î, Á¤¹ÐÇÑ °ü·ù °ü¸® ¹× °ü·ù ±â¼úÀÚÀÇ ¿öÅ©Ç÷οì È¿À²À» Áö¿øÇÏ´Â °ÍÀÌ Æ¯Â¡ÀÔ´Ï´Ù. µ¥ÀÌÅÍ ÅëÇÕ ±â´ÉÀ» ÅëÇØ ¼ö¼ú Áß ÀÇ»ç°áÁ¤ ¹× ¼ö¼ú ÈÄ ºÐ¼®À» °³¼±Çϰí, ¸ðµâ½Ä ½Ã½ºÅÛÀ» ÅëÇØ ½Ã¼ú À¯Çü, ȯÀÚ ÇÁ·ÎÆÄÀÏ, ½Ã¼³ ÇÁ·ÎÅäÄÝ¿¡ µû¶ó À¯¿¬ÇÏ°Ô ±¸¼ºÇÒ ¼ö ÀÖ½À´Ï´Ù.

CPB ±â±â ½ÃÀå È®´ë¸¦ ÁÖµµÇÏ´Â ÀÓ»ó¿ëµµ, Áö¿ª ½ÃÀå, ÇコÄÉ¾î ¸ðµ¨Àº?

ÁÖ¿ä ÀÓ»ó ÀÌ¿ë »ç·Ê·Î´Â ¼ºÀÎ ¹× ¼Ò¾Æ °³½É¼ú, °íÀ§Çè Àç¼ö¼ú, ½ÉÁ¤Áö ¹× ¿Ü»ó¿¡ ´ëÇÑ ÀÀ±Þ °³ÀÔ µîÀÌ ÀÖ½À´Ï´Ù. ƯÈ÷ 3Â÷ ½ÉÀå Ä¡·á ¼¾ÅÍ, ÀÌ½Ä ¼ö¼ú½Ç, ¼Ò¾Æ ½ÉÀå Àü¹® ÇÁ·Î±×·¥¿¡¼­ ¼ö¿ä°¡ ³ô½À´Ï´Ù. ÇÏÀ̺긮µå ¼ö¼ú½Ç°ú ÃÖ¼Òħ½À½ÉÀå¼ö¼ú(MICS) ¼¾ÅÍ¿¡¼­ÀÇ CPB Àåºñ äÅõµ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

ºÏ¹Ì¿Í À¯·´Àº ³ôÀº ¼ö¼ú °Ç¼ö, ÷´ÜÈ­µÈ º´¿ø ÀÎÇÁ¶ó, ´ëÇü ÀÇ·á±â±â ¾÷üµéÀÇ °­·ÂÇÑ Á¸Àç°¨À¸·Î ÀÎÇØ ¿©ÀüÈ÷ Áö¹èÀûÀÎ ½ÃÀåÀ¸·Î ³²¾Æ ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº Àεµ, Áß±¹, Çѱ¹ µîÀÇ ±¹°¡¿¡¼­ ½ÉÇ÷°ü Áúȯ À¯º´·ü Áõ°¡, ½ÉÀå ¼ö¼ú Àåºñ¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡, Àü¹® ÀÇ·áÁø¿¡ ÀÇÇÑ Ä¡·á Á¢±Ù¼º È®´ë µîÀ» ¹è°æÀ¸·Î ±Þ¼ºÀåÇϰí ÀÖ½À´Ï´Ù.

°ø°ø ¹× ¹Î°£ º´¿ø, ´ëÇÐ ÀÇ·á ¼¾ÅÍ, ½ÉÀå Àü¹® ÀÇ·á ±â°üÀÌ ÁÖ¿ä ÃÖÁ¾»ç¿ëÀÚÀÔ´Ï´Ù. Àåºñ °ø±Þ¾÷üµéÀº CPB Àåºñ¿¡ ¼Ò¸ðǰ, À¯Áöº¸¼ö ¼­ºñ½º, ÀÓ»ó ±³À°À» ¹øµé·Î Á¦°øÇÏ´Â Á¾ÇÕÀûÀÎ °ü·ù Ç÷§ÆûÀ» Á¦°øÇÏ¿© ´ë±Ô¸ð º´¿ø ½Ã½ºÅÛ Àüü¿¡¼­ Ä¡·áÀÇ ¿¬¼Ó¼º°ú ±â¼ú Ç¥ÁØÈ­¸¦ º¸ÀåÇϰí ÀÖ½À´Ï´Ù.

½ÉÆó ¿ìȸ Àåºñ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

CPB ±â±â ½ÃÀåÀº Àü ¼¼°è ½ÉÀå ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, »ýÁ¸ ¿¹ÈÄ °³¼±, ü¿Ü º¸Á¶ ±â¼ú¿¡ ´ëÇÑ ½Å·Úµµ Áõ°¡¿Í ÇÔ²² ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. º¹ÀâÇÑ ½ÉÇ÷°ü°è ÁúȯÀÇ ºÎ´ãÀÌ Áõ°¡ÇÔ¿¡ µû¶ó CPB ½Ã½ºÅÛÀº ÁßȯÀÚ Ä¡·á ȯ°æ¿¡¼­ ¼ö¼úÀû ±³Á¤, ȸº¹À» À§ÇÑ °¡±³ ÁßÀç, ÷´Ü »ý¸í À¯Áö¸¦ °¡´ÉÇÏ°Ô ÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù.

ÁÖ¿ä ¼ºÀå ÃËÁø¿äÀÎÀ¸·Î´Â Àü ¼¼°è °³½É¼ú Áõ°¡, »ýü ÀûÇÕ¼º ¹× ¼ÒÇüÈ­ ½Ã½ºÅÛÀÇ Çõ½Å, ÁßȯÀڽǿ¡¼­ÀÇ ECMO »ç¿ë Áõ°¡, ¼Ò¾Æ ½ÉÀå ¼ö¼ú ÇÁ·Î±×·¥ÀÇ È®´ë, °ü·ù ±â¼ú¿¡ ´ëÇÑ ½Ã¼³ ÅõÀÚ Áõ°¡ µîÀÌ ÀÖ½À´Ï´Ù. ¼ö¼ú ±â¹ýÀÇ °³¼±°ú ½Ç½Ã°£ ¸ð´ÏÅ͸µ ÅøÀº À§Çè °¨¼Ò¿Í ¼ö¼ú ÈÄ È¸º¹¿¡ ÀÖÀ¸¸ç, CPBÀÇ °¡Ä¡¸¦ ³ôÀ̰í ÀÖ½À´Ï´Ù.

¼ö¼úÀÇ Çõ½ÅÀÌ ÁßȯÀÚ Ä¡·á ¼ö¿ä¿¡ ¼ö·ÅÇÔ¿¡ µû¶ó ½ÉÆó ¹ÙÀÌÆÐ½º ½Ã½ºÅÛÀº Â÷¼¼´ë ÷´Ü ±Þ¼º ½ÉÇ÷°ü Ä¡·á¸¦ Áö¿øÇÏ´Â ÅëÇÕ Ã¼¿Ü Ç÷§ÆûÀ¸·Î ÁøÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù.

ºÎ¹®

Á¦Ç° À¯Çü(½Ì±Û ·Ñ·¯ ÆßÇÁ, ´õºí ·Ñ·¯ ÆßÇÁ); ÃÖÁ¾»ç¿ëÀÚ(º´¿ø, ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ, ±âŸ ÃÖÁ¾»ç¿ëÀÚ)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹(ÁÖ¸ñ 36»ç)

AI ÅëÇÕ

¿ì¸®´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI Åø¿¡ ÀÇÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM³ª ¾÷°è °íÀ¯ SLM¸¦ Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹ü¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾ç ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è µµ¸ÞÀÎ Àü¹®°¡·ÎºÎÅÍ Å¥·¹ÀÌÆ®µÈ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÔ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Cardiopulmonary Bypass Equipment Market to Reach US$220.9 Million by 2030

The global market for Cardiopulmonary Bypass Equipment estimated at US$199.0 Million in the year 2024, is expected to reach US$220.9 Million by 2030, growing at a CAGR of 1.8% over the analysis period 2024-2030. Single Roller Pump, one of the segments analyzed in the report, is expected to record a 1.4% CAGR and reach US$147.2 Million by the end of the analysis period. Growth in the Double Roller Pump segment is estimated at 2.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$54.2 Million While China is Forecast to Grow at 3.3% CAGR

The Cardiopulmonary Bypass Equipment market in the U.S. is estimated at US$54.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$40.5 Million by the year 2030 trailing a CAGR of 3.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.7% and 1.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.0% CAGR.

Global Cardiopulmonary Bypass Equipment Market - Key Trends & Drivers Summarized

Why Is Cardiopulmonary Bypass Equipment Gaining Strategic Importance Across Cardiac Surgery, Critical Care, and Extracorporeal Life Support?

Cardiopulmonary bypass (CPB) equipment remains a cornerstone of cardiac surgery, enabling temporary circulatory and respiratory support during procedures that require the heart and lungs to be safely bypassed. Widely used in coronary artery bypass grafting (CABG), valve replacement, congenital defect repair, and complex aortic surgeries, this equipment allows surgeons to operate in a motionless, bloodless field while ensuring systemic perfusion and oxygenation. As the global incidence of cardiovascular disease rises and surgical volumes grow in both developed and emerging regions, CPB equipment is gaining renewed strategic relevance in supporting life-sustaining interventions.

Beyond conventional open-heart surgeries, cardiopulmonary bypass systems are also increasingly integrated into extracorporeal life support (ECLS) and extracorporeal membrane oxygenation (ECMO) protocols for critical care patients with cardiogenic shock, acute respiratory distress syndrome (ARDS), or post-cardiotomy complications. These expanded applications are reinforcing CPB’s role not only as a surgical tool but as a vital component of intensive care and life-saving rescue therapies in high-acuity environments.

How Are System Miniaturization, Biocompatible Materials, and Automation Enhancing CPB Equipment Performance?

Technological advances are driving next-generation CPB systems that are more compact, efficient, and patient-centric. Miniaturized perfusion circuits, integrated oxygenators, and lower priming volumes are reducing hemodilution, inflammatory response, and procedural complexity. Centrifugal pumps are replacing roller pumps in many settings due to improved blood handling and lower shear stress, while closed-loop circuitry and biocompatible coatings (e.g., heparin-bonded surfaces) are enhancing safety and reducing the risk of thromboembolism or systemic inflammatory response syndrome (SIRS).

Advanced systems feature touch-screen interfaces, real-time parameter monitoring, and automated controls for temperature, flow rate, and gas exchange-supporting precision perfusion management and perfusionist workflow efficiency. Data integration capabilities are improving intraoperative decision-making and postoperative analysis, while modular systems enable configuration flexibility based on procedure type, patient profile, and institutional protocols.

Which Clinical Applications, Regional Markets, and Healthcare Models Are Driving CPB Equipment Market Expansion?

Key clinical use cases include adult and pediatric open-heart surgery, high-risk reoperations, and emergency interventions for cardiac arrest or trauma. Demand is particularly strong in tertiary cardiac care centers, transplant units, and specialized pediatric cardiac programs. The adoption of CPB equipment in hybrid operating rooms and minimally invasive cardiac surgery (MICS) centers is also contributing to market expansion.

North America and Europe remain dominant markets due to high surgical volumes, availability of advanced hospital infrastructure, and strong presence of leading medical device manufacturers. Asia-Pacific is witnessing rapid growth, driven by rising cardiovascular disease prevalence, growing investments in cardiac surgery capacity, and expanding access to specialist care in countries such as India, China, and South Korea.

Public and private hospitals, academic medical centers, and specialty cardiac institutions are the primary end-users. Equipment suppliers are increasingly offering comprehensive perfusion platforms that bundle CPB devices with disposables, maintenance services, and clinical training-ensuring continuity of care and technology standardization across large hospital systems.

What Are the Factors Driving Growth in the Cardiopulmonary Bypass Equipment Market?

The CPB equipment market is expanding in parallel with rising global cardiac surgical needs, improved survival outcomes, and growing reliance on extracorporeal support technologies. As the burden of complex cardiovascular conditions escalates, CPB systems are indispensable in enabling surgical correction, bridge-to-recovery interventions, and advanced life support in critical care settings.

Key growth drivers include the increasing number of open-heart procedures worldwide, innovation in biocompatible and miniaturized systems, rising use of ECMO in ICUs, expanding pediatric cardiac surgery programs, and growing institutional investments in perfusion technology. Enhanced surgical techniques and real-time monitoring tools are reinforcing CPB’s value in risk mitigation and postoperative recovery.

As surgical innovation converges with critical care demands, could cardiopulmonary bypass systems evolve into integrated extracorporeal platforms anchoring the next generation of high-acuity cardiovascular interventions?

SCOPE OF STUDY:

The report analyzes the Cardiopulmonary Bypass Equipment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Single Roller Pump, Double Roller Pump); End-User (Hospitals, Ambulatory Surgery Centers, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â